AngioDynamics Company Profile (NASDAQ:ANGO)

About AngioDynamics

AngioDynamics logoAngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease, and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include fluid management, venous, thrombus management, as well as other core products. The Company's BioFlo products incorporate Endexo technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its microwave ablation products, its radiofrequency ablation (RFA) and its NanoKnife product lines.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ANGO
  • CUSIP: 03475V10
Key Metrics:
  • Previous Close: $17.40
  • 50 Day Moving Average: $16.50
  • 200 Day Moving Average: $13.99
  • 52-Week Range: $9.71 - $17.54
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 23.20
  • P/E Growth: 1.53
  • Market Cap: $625.37M
  • Outstanding Shares: 36,422,000
  • Beta: 1.04
Profitability:
  • Net Margins: -12.57%
  • Return on Equity: 3.94%
  • Return on Assets: 2.82%
Debt:
  • Debt-to-Equity Ratio: 0.21%
  • Current Ratio: 2.19%
  • Quick Ratio: 1.36%
Additional Links:
Companies Related to AngioDynamics:

Analyst Ratings

Consensus Ratings for AngioDynamics (NASDAQ:ANGO) (?)
Ratings Breakdown: 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $14.50 (15.55% downside)

Analysts' Ratings History for AngioDynamics (NASDAQ:ANGO)
Show:
DateFirmActionRatingPrice TargetDetails
9/12/2016KeyCorpSet Price TargetBuy$18.00View Rating Details
4/8/2016Piper Jaffray Cos.Initiated CoverageNeutral$12.00View Rating Details
4/5/2016Canaccord GenuityDowngradeBuy -> Hold$14.50 -> $13.00View Rating Details
11/10/2015Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
9/23/2015SidotiInitiated CoverageNeutral$14.50View Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for AngioDynamics (NASDAQ:ANGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/6/2016        
7/13/2016Q416$0.16$0.19$88.64 million$93.40 millionViewListenView Earnings Details
4/7/2016Q3$0.14$0.15$87.40 millionViewListenView Earnings Details
1/7/2016Q216$0.14$0.14$88.67 million$89.20 millionViewN/AView Earnings Details
10/8/2015Q116$0.11$0.11$83.70 millionViewN/AView Earnings Details
7/16/2015Q415$0.14$0.14$91.67 million$90.90 millionViewListenView Earnings Details
4/9/2015Q315$0.16$0.12$86.60 millionViewN/AView Earnings Details
1/8/2015Q215$0.15$0.17$90.90 million$92.10 millionViewN/AView Earnings Details
10/9/2014Q115$0.11$0.16$87.30 millionViewListenView Earnings Details
7/23/2014Q414$0.12$0.18$93.65 million$94.07 millionViewListenView Earnings Details
4/9/2014Q314$0.09$0.16$86.85 million$88.20 millionViewListenView Earnings Details
1/9/2014Q2$0.07$0.14$87.54 million$88.60 millionViewListenView Earnings Details
10/10/2013Q114$0.03$0.04$82.54 million$83.60 millionViewN/AView Earnings Details
7/11/2013Q4 2013$0.06$0.07$86.43 million$90.00 millionViewN/AView Earnings Details
4/8/2013Q3 2013$0.05$0.08$81.70 million$81.60 millionViewN/AView Earnings Details
1/3/2013Q2 2013$0.09$0.10$87.40 million$87.00 millionViewN/AView Earnings Details
10/8/2012Q113$0.09$0.10$84.35 million$83.40 millionViewN/AView Earnings Details
7/12/2012$0.08$0.09ViewN/AView Earnings Details
4/4/2012$0.07$0.09ViewN/AView Earnings Details
1/5/2012$0.12$0.13ViewN/AView Earnings Details
10/6/2011$0.09$0.08ViewN/AView Earnings Details
7/14/2011$0.10$0.11ViewN/AView Earnings Details
4/5/2011$0.12$0.15ViewN/AView Earnings Details
1/4/2011$0.12$0.13ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AngioDynamics (NASDAQ:ANGO)
Current Year EPS Consensus Estimate: $0.63 EPS
Next Year EPS Consensus Estimate: $0.74 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.12$0.15$0.14
Q2 20162$0.16$0.17$0.17
Q1 20171$0.13$0.13$0.13
Q2 20171$0.16$0.16$0.16
Q3 20171$0.17$0.17$0.17
Q4 20171$0.19$0.19$0.19
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AngioDynamics (NASDAQ:ANGO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AngioDynamics (NASDAQ:ANGO)
Insider Ownership Percentage: 1.88%
Institutional Ownership Percentage: 69.29%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/5/2016Avista Capital Partners Gp, LlMajor ShareholderSell2,241,000$14.62$32,763,420.00View SEC Filing  
8/5/2016David F BurgstahlerDirectorSell2,250,000$14.62$32,895,000.00View SEC Filing  
5/6/2016Charles R GreinerVPSell3,508$12.31$43,183.48View SEC Filing  
4/25/2016Stephen A TrowbridgeSVPSell12,940$12.30$159,162.00View SEC Filing  
4/14/2014Matthew KapustaSVPBuy1,000$13.90$13,900.00View SEC Filing  
10/18/2013Vincent BucciDirectorBuy5,000$15.20$76,000.00View SEC Filing  
10/17/2013Howard W DonnellyDirectorSell20,000$15.06$301,200.00View SEC Filing  
7/22/2013Kevin J GouldDirectorBuy2,700$12.00$32,400.00View SEC Filing  
5/9/2013Charles R GreinerVPSell1,495$10.38$15,518.10View SEC Filing  
3/12/2013Vincent BucciDirectorBuy85,000$10.77$915,450.00View SEC Filing  
2/14/2013Vincent BucciDirectorBuy2,000$12.17$24,340.00View SEC Filing  
1/11/2013Kevin J GouldDirectorBuy2,700$11.58$31,266.00View SEC Filing  
11/5/2012Jeffrey GoldDirectorBuy1,000$10.56$10,560.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AngioDynamics (NASDAQ:ANGO)
DateHeadline
mysmartrend.com logoAngiodynamics Shares Up 53.0% Since SmarTrend's Buy Recommendation (ANGO) (NASDAQ:ANGO)
www.mysmartrend.com - September 22 at 3:27 PM
finance.yahoo.com logoAngioDynamics Hits New 52-Week High on Solid Q4 Results (NASDAQ:ANGO)
finance.yahoo.com - September 22 at 3:27 PM
publicnow.com logoAngioDynamics to Report Fiscal 2017 First Quarter Financial Results (NASDAQ:ANGO)
www.publicnow.com - September 21 at 8:58 AM
prnewswire.com logoPurcell Julie & Lefkowitz LLP (NASDAQ:ANGO)
www.prnewswire.com - September 19 at 4:27 PM
4-traders.com logoPurcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (NASDAQ:ANGO)
www.4-traders.com - September 19 at 4:27 PM
News IconSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Dut... (NASDAQ:ANGO)
ih.advfn.com - September 19 at 4:27 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating AngioDynamics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (NASDAQ:ANGO)
finance.yahoo.com - September 19 at 8:15 AM
mysmartrend.com logo42.5% Return Seen to Date on SmarTrend Angiodynamics Call (ANGO) (NASDAQ:ANGO)
www.mysmartrend.com - September 15 at 3:29 PM
capitalcube.com logoETF’s with exposure to AngioDynamics, Inc. : September 15, 2016 (NASDAQ:ANGO)
www.capitalcube.com - September 15 at 12:25 PM
biz.yahoo.com logoANGIODYNAMICS INC Files SEC form 8-K/A, Change in Directors or Principal Officers (NASDAQ:ANGO)
biz.yahoo.com - September 9 at 8:19 AM
finance.yahoo.com logoAngioDynamics to Present at the 2016 Morgan Stanley Global Healthcare Conference (NASDAQ:ANGO)
finance.yahoo.com - September 6 at 3:28 PM
capitalcube.com logoETF’s with exposure to AngioDynamics, Inc. : August 31, 2016 (NASDAQ:ANGO)
www.capitalcube.com - August 31 at 3:31 PM
mysmartrend.com logo47.2% Return Seen to Date on SmarTrend Angiodynamics Call (ANGO) (NASDAQ:ANGO)
www.mysmartrend.com - August 31 at 8:18 AM
mysmartrend.com logoAngiodynamics Shares Up 45.1% Since SmarTrend's Buy Recommendation (ANGO) (NASDAQ:ANGO)
www.mysmartrend.com - August 23 at 8:48 PM
bizjournals.com logoAngioDynamics on hiring spree at Queensbury plant after competitor's recall (NASDAQ:ANGO)
www.bizjournals.com - August 17 at 3:33 PM
mysmartrend.com logoAngiodynamics Up 40.3% Since SmarTrend Uptrend Call (ANGO) (NASDAQ:ANGO)
www.mysmartrend.com - August 17 at 11:43 AM
publicnow.com logoAngioDynamics to Present at the 2016 Canaccord Genuity Growth Conference (NASDAQ:ANGO)
www.publicnow.com - August 8 at 3:32 PM
finance.yahoo.com logoANGIODYNAMICS INC Financials (NASDAQ:ANGO)
finance.yahoo.com - August 6 at 3:38 PM
biz.yahoo.com logoANGIODYNAMICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Of (NASDAQ:ANGO)
biz.yahoo.com - August 5 at 8:54 PM
publicnow.com logoAngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders (NASDAQ:ANGO)
www.publicnow.com - August 2 at 8:18 AM
biz.yahoo.com logoANGIODYNAMICS INC Files SEC form 10-K, Annual Report (NASDAQ:ANGO)
biz.yahoo.com - August 1 at 3:31 PM
4-traders.com logoAngioDynamics : Issues Statement Regarding Stryker recall of Angiographic Catheters (NASDAQ:ANGO)
www.4-traders.com - July 27 at 11:44 AM
News IconAngioDynamics names new CFO (NASDAQ:ANGO)
www.malaysiasun.com - July 25 at 9:34 PM
capitalcube.com logoETF’s with exposure to AngioDynamics, Inc. : July 25, 2016 (NASDAQ:ANGO)
www.capitalcube.com - July 25 at 1:17 PM
publicnow.com logoAngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer (NASDAQ:ANGO)
www.publicnow.com - July 25 at 7:48 AM
capitalcube.com logoAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q4, 2016 By the Numbers : July 22, 2016 (NASDAQ:ANGO)
www.capitalcube.com - July 22 at 11:17 AM
capitalcube.com logoAngioDynamics, Inc. :ANGO-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016 (NASDAQ:ANGO)
www.capitalcube.com - July 22 at 9:06 AM
equities.com logoAngioDynamics Inc. (ANGO) Hits New 52-week High During July 18 Session (NASDAQ:ANGO)
www.equities.com - July 20 at 10:58 PM
globenewswire.com logoAngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results (NASDAQ:ANGO)
globenewswire.com - July 13 at 8:59 PM
News IconAngioDynamics new CEO looks to growth opportunities after 2016 loss (NASDAQ:ANGO)
www.malaysiasun.com - July 13 at 8:59 PM
4-traders.com logoAngioDynamics : reports 4Q loss (NASDAQ:ANGO)
www.4-traders.com - July 13 at 8:59 PM
marketwatch.com logoAngioDynamics revenue beats but outlook lags (NASDAQ:ANGO)
www.marketwatch.com - July 13 at 8:59 PM
equities.com logoAngioDynamics Inc. (ANGO) Jumps 9.93% on July 13 (NASDAQ:ANGO)
www.equities.com - July 13 at 8:59 PM
finance.yahoo.com logoEdited Transcript of ANGO earnings conference call or presentation 13-Jul-16 12:00pm GMT (NASDAQ:ANGO)
finance.yahoo.com - July 13 at 2:40 PM
feeds.benzinga.com logoThe Market In 5 Minutes: Indexes Are At All-Time Highs (NASDAQ:ANGO)
feeds.benzinga.com - July 13 at 10:15 AM
biz.yahoo.com logoQ4 2016 AngioDynamics Inc Earnings Release - Before Market Open (NASDAQ:ANGO)
biz.yahoo.com - July 13 at 7:07 AM
sg.finance.yahoo.com logoAngioDynamics reports 4Q loss (NASDAQ:ANGO)
sg.finance.yahoo.com - July 13 at 6:23 AM
equities.com logoAngioDynamics Inc. (ANGO) is Trading Lower on Unusual Volume for July 11 (NASDAQ:ANGO)
www.equities.com - July 12 at 8:58 PM
finance.yahoo.com logoCan AngioDynamics' (ANGO) Q4 Earnings Pull a Surprise? (NASDAQ:ANGO)
finance.yahoo.com - July 8 at 10:25 AM
capitalcube.com logoETF’s with exposure to AngioDynamics, Inc. : July 1, 2016 (NASDAQ:ANGO)
www.capitalcube.com - July 1 at 5:51 PM
twst.com logoAngioDynamics Inc.: AngioDynamics to Report Fiscal 2016 Fourth Quarter and Full Year Financial Results (NASDAQ:ANGO)
www.twst.com - June 29 at 11:43 AM
finance.yahoo.com logoAngioDynamics to Report Fiscal 2016 Fourth Quarter and Full Year Financial Results (NASDAQ:ANGO)
finance.yahoo.com - June 29 at 6:00 AM
capitalcube.com logoETF’s with exposure to AngioDynamics, Inc. : June 17, 2016 (NASDAQ:ANGO)
www.capitalcube.com - June 17 at 5:05 PM
capitalcube.com logoAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2016 By the Numbers : June 14, 2016 (NASDAQ:ANGO)
www.capitalcube.com - June 14 at 10:18 AM
bizjournals.com logo2 more executives leave one of Albany's biggest public companies (NASDAQ:ANGO)
www.bizjournals.com - April 21 at 9:20 AM
bizjournals.com logoNew AngioDynamics CEO: I'll focus on current business now, M&A next phase (NASDAQ:ANGO)
www.bizjournals.com - April 21 at 9:08 AM
biz.yahoo.com logoANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:ANGO)
biz.yahoo.com - April 20 at 8:51 AM
capitalcube.com logoETF’s with exposure to AngioDynamics, Inc. : April 14, 2016 (NASDAQ:ANGO)
www.capitalcube.com - April 14 at 2:47 PM
capitalcube.com logoAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2016 By the Numbers (NASDAQ:ANGO)
www.capitalcube.com - April 13 at 9:24 AM
capitalcube.com logoAngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : April 12, 2016 (NASDAQ:ANGO)
www.capitalcube.com - April 12 at 3:23 PM

Social

AngioDynamics (NASDAQ:ANGO) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff